# Changchun BCHT Biotechnology Co. clinical trials: 22 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials with Changchun BCHT Biotechnology Co. as lead sponsor, 7 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Changchun BCHT Biotechnology Co.: 22 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/changchun-bcht-biotechnology-co

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 7
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 26, 2026 | NCT07894055 | A Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) | Changchun BCHT Biotechnology Co. | Phase 2 | Recruiting | Pertussis (Whooping Cough), Diphtheria, Tetanus | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07894055) |
| August 7, 2026 | NCT07753265 | A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine | Changchun BCHT Biotechnology Co. | Early phase 1 | Not yet recruiting | Herpse Zoster | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753265) |
| June 8, 2026 | NCT07633197 | A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) | Changchun BCHT Biotechnology Co. | Phase 1 | Enrolling by invitation | Herpes | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07633197) |
| April 22, 2026 | NCT07545564 | A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza Vaccine | Changchun BCHT Biotechnology Co. | Phase 4 | Enrolling by invitation | Influenza | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07545564) |
| March 30, 2026 | NCT07500207 | A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell) | Changchun BCHT Biotechnology Co. | Phase 3 | Enrolling by invitation | Rabies Prevention | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07500207) |
| March 25, 2026 | NCT07492303 | A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) | Changchun BCHT Biotechnology Co. | Phase 1 | Not yet recruiting | Pertussis (Whooping Cough), Diphtheria, Tetanus | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492303) |
| January 16, 2026 | NCT07349017 | A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant) | Changchun BCHT Biotechnology Co. | Phase 1 | Not yet recruiting | Influenza | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07349017) |
| January 14, 2026 | NCT07338786 | A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid... | Changchun BCHT Biotechnology Co. | Phase 1 | Enrolling by invitation | RabiesPrevention | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07338786) |
| January 9, 2026 | NCT07330440 | A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2)... | Changchun BCHT Biotechnology Co. | Phase 1 | Enrolling by invitation | Genital Herpes | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07330440) |
| August 21, 2025 | NCT07133802 | Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged... | Changchun BCHT Biotechnology Co. | Phase 3 | Not yet recruiting | Prevention of Influenza | 6,680 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07133802) |
| August 8, 2025 | NCT07112144 | Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial | Changchun BCHT Biotechnology Co. | Phase 3 | Recruiting | Prevent Whooping Cough, Prevent Diphtheria, Prevent Tetanus | 1,650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07112144) |
| May 8, 2025 | NCT06961721 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live... | Changchun BCHT Biotechnology Co. | Phase 4 | Not yet recruiting | Prevention of Herpes Zoster | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06961721) |
| August 12, 2024 | NCT06548139 | Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials | Changchun BCHT Biotechnology Co. | Phase 2 | Unknown | Rabies Virus Infection | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06548139) |
| April 11, 2024 | NCT06360250 | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82... | Changchun BCHT Biotechnology Co. | Early phase 1 | Unknown | Clostridium Tetanus | 190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06360250) |
| February 28, 2024 | NCT06280144 | Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine | Changchun BCHT Biotechnology Co. | Phase 4 | Unknown | Influenza Prevention | 6,080 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06280144) |
| April 27, 2023 | NCT05832073 | Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1 | Changchun BCHT Biotechnology Co. | Early phase 1 | Unknown | Rabies Virus Infection | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05832073) |
| March 17, 2022 | NCT05284851 | The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine | Changchun BCHT Biotechnology Co. | Phase 2 | Unknown | Influenza Prevention | 2,520 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05284851) |
| January 12, 2022 | NCT05189548 | To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children... | Changchun BCHT Biotechnology Co. | Phase 1/2 | Unknown | Safety、Immunogenicity | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05189548) |
| September 24, 2021 | NCT05056519 | The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine | Changchun BCHT Biotechnology Co. | Phase 1 | Unknown | Influenza Prevention | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05056519) |
| April 1, 2021 | NCT04825340 | To Explore a Bridging Index for the Effectiveness of the Clinical Trial | Changchun BCHT Biotechnology Co. | Not applicable | Unknown | Randomized | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04825340) |
| April 6, 2020 | NCT04334577 | Study on Efficacy of Attenuated Zoster Vaccine, Live | Changchun BCHT Biotechnology Co. | Phase 3 | Completed | Herpes Zoster | 25,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04334577) |
| November 15, 2016 | NCT02964065 | A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV) | Changchun BCHT Biotechnology Co. | Phase 3 | Completed | Influenza | 9,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02964065) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 3 |
| Phase 1 | 6 |
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Phase 3 | 5 |
| Phase 4 | 3 |
| Not applicable | 1 |

## By status

| Status | Trials |
| --- | --- |
| Unknown | 8 |
| Enrolling by invitation | 5 |
| Not yet recruiting | 5 |
| Recruiting | 2 |
| Completed | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Influenza, Human | 3 |
| Rabies | 2 |
| Whooping Cough | 2 |
| Diphtheria | 2 |
| Tetanus | 2 |
| Herpes Zoster | 2 |
| Herpes Simplex | 1 |
| Herpes Genitalis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Biotechnology companies in the United States](https://specstream.ai/data/businesses/biotechnology-companies/united-states)
- [Medical schools in the United States](https://specstream.ai/data/businesses/medical-schools/united-states)
- [Paralegal companies in the United States](https://specstream.ai/data/businesses/paralegal-companies/united-states)
- [Psychiatry practices in the United States](https://specstream.ai/data/businesses/psychiatry-practices/united-states)
- [Smoothie and juice bars in the United States](https://specstream.ai/data/businesses/smoothie-and-juice-bars/united-states)
- [Trailer rental companies in the United States](https://specstream.ai/data/businesses/trailer-rental-companies/united-states)
